Xinxin Yang

Department Of Head And Neck Genitourinary Medicine
Harbin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

High dose IFN-α2b as post operative adjuvant therapy for acral melanoma: a multi-center real-world cohort study of 171 Chinese patients.

High dose IFN-α2b as post operative adjuvant therapy for acral melanoma: a multi-center real-world cohort study of 171 Chinese patients.

Journal: Frontiers in oncology
Published: May 20, 2026

Preoperative conversion therapy of camrelizumab combined with paclitaxel and nedaplatin for unresectable advanced esophageal squamous cell carcinoma: a phase 2 study.

Preoperative conversion therapy of camrelizumab combined with paclitaxel and nedaplatin for unresectable advanced esophageal squamous cell carcinoma: a phase 2 study.

Journal: BMC medicine
Published: October 30, 2025

Enhanced tumor heterogeneity mediates poor prognosis in females with TP53 mutation in lung adenocarcinoma.

Enhanced tumor heterogeneity mediates poor prognosis in females with TP53 mutation in lung adenocarcinoma.

Journal: International journal of biological macromolecules
Published: October 25, 2025

Response to Zhao et al, "Comment on 'Nevus-associated acral melanoma has lower risk of recurrence and mortality than de novo acral melanoma'".

Response to Zhao et al, "Comment on 'Nevus-associated acral melanoma has lower risk of recurrence and mortality than de novo acral melanoma'".

Journal: Journal of the American Academy of Dermatology
Published: July 18, 2025

SQLE drives bladder cancer progression by boosting mitochondrial oxidative phosphorylation.

SQLE drives bladder cancer progression by boosting mitochondrial oxidative phosphorylation.

Journal: Oncogene
Published: July 08, 2025

Implementing liquid biopsy NGS in stage III/IV NSCLC: clinical utility assessment from a real-world Chinese cohort.

Implementing liquid biopsy NGS in stage III/IV NSCLC: clinical utility assessment from a real-world Chinese cohort.

Journal: BMC cancer
Published: June 26, 2025

NAT10 drives hepatocellular carcinoma progression through SQLE-mediated cholesterol biosynthesis and is targetable by remodelin.

NAT10 drives hepatocellular carcinoma progression through SQLE-mediated cholesterol biosynthesis and is targetable by remodelin.

Journal: iScience
Published: June 19, 2025

Enhanced prediction of gene mutation and risk stratification in non-small-cell lung cancer through dual-pathway fusion of radiomics and pathomics.

Enhanced prediction of gene mutation and risk stratification in non-small-cell lung cancer through dual-pathway fusion of radiomics and pathomics.

Journal: Frontiers in oncology
Published: June 14, 2025

Post-translational switch of DHCR24 acetylation sustains sterol synthesis and promotes HCC via the 7-ketocholesterol/p62 axis.

Post-translational switch of DHCR24 acetylation sustains sterol synthesis and promotes HCC via the 7-ketocholesterol/p62 axis.

Journal: Cell reports
Published: May 19, 2025

RFX2-BNIP3 axis-driven adaptive mitophagy promotes resistance to ACK1-targeted therapy in non-small cell lung cancer.

RFX2-BNIP3 axis-driven adaptive mitophagy promotes resistance to ACK1-targeted therapy in non-small cell lung cancer.

Journal: Oncogene
Published: December 21, 2024

Extratumoral Signs of Malignant Nonspiculate and Noncalcified Masses on Mammography: Are They Associated With Prognostic Factors in Breast Cancer?

Extratumoral Signs of Malignant Nonspiculate and Noncalcified Masses on Mammography: Are They Associated With Prognostic Factors in Breast Cancer?

Journal: The breast journal
Published: November 21, 2024

Delactylation diminished the growth inhibitory role of CA3 by restoring DUOX2 expression in hepatocellular carcinoma.

Delactylation diminished the growth inhibitory role of CA3 by restoring DUOX2 expression in hepatocellular carcinoma.

Journal: Experimental cell research
Published: October 29, 2024
Showing 1-12 of 34

Last Updated: 09/26/2026